Covered recipient · General Payments record
REBECCA RUGEN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2025
$2,938.50
- Reported across 178 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $149.23 | 9 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $28.16 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $25.06 | 1 |
| Lilly USA, LLC | $20.88 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $15.50 | 1 |
| Exact Sciences Corporation | $15.43 | 1 |
| Novo Nordisk AS | $15.34 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.80 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.06 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Aimmune Therapeutics, Inc. | $15.50 | 01/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249702265 | CMS |
| Amgen Inc. | $14.01 | 02/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227049054 | CMS |
| Amgen Inc. | $14.15 | 02/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227049052 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.06 | 03/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222950199 | CMS |
| Exact Sciences Corporation | $15.43 | 02/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235426393 | CMS |
| Lilly USA, LLC | $20.88 | 02/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186929666 | CMS |
| Novartis Pharmaceuticals Corporation | $25.06 | 02/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200514327 | CMS |
| Novo Nordisk Inc | $15.34 | 04/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189017583 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.80 | 02/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231987083 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.